Similar articles

• The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review.

  Kranke P, Morin AM, Roewer N, Wulf H, Eberhart LH. Kranke P, et al. Anesth Analg. 2002 Jul;95(1):133-43, table of contents. doi: 10.1097/00000539-200207000-00024. Anesth Analg. 2002. PMID: 12088957
• Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery.

  Sah N, Ramesh V, Kaul B, Dalby P, Shestak K, Vallejo MC. Sah N, et al. J Clin Anesth. 2009 Jun;21(4):249-52. doi: 10.1016/j.jclinane.2008.08.017. Epub 2009 Jun 6. J Clin Anesth. 2009. PMID: 19502023 Clinical Trial.
• The effect of transdermal scopolamine on the incidence and severity of postoperative nausea and vomiting in a group of high-risk patients given prophylactic intravenous ondansetron.

  Jones S, Strobl R, Crosby D, Burkard JF, Maye J, Pellegrini JE. Jones S, et al. AANA J. 2006 Apr;74(2):127-32. AANA J. 2006. PMID: 16617916 Clinical Trial.
• Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting.

  Pergolizzi JV Jr, Philip BK, Leslie JB, Taylor R Jr, Raffa RB. Pergolizzi JV Jr, et al. J Clin Anesth. 2012 Jun;24(4):334-45. doi: 10.1016/j.jclinane.2011.07.019. J Clin Anesth. 2012. PMID: 22608591 Review.
• [Efficiency of using ondansetron in the surgical treatment of post-burn cicatricial deformity in children with a history of postoperative nausea and vomiting].

  Lekmanov AU, Tkachenko BA, Suvorov SG. Lekmanov AU, et al. Anesteziol Reanimatol. 2008 Jan-Feb;(1):21-3. Anesteziol Reanimatol. 2008. PMID: 18368834 Clinical Trial. Russian.